Intensity Therapeutics, Inc. Common stock
Symbol: INTS (NASDAQ)
0.26
▲ (8.36%) 0.020
Company Description:
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
Key Stats
- Today's Open: $0.2556
- Today's High: $0.287
- Today's Low: $0.253
- Today's Volume: 3.50M
- Yesterday Close: $0.2427
- Yesterday High: $0.253
- Yesterday Low: $0.24
- Yesterday Volume: 4.49M
- Last Min Volume: 38.10K
- Last Min High: $0.263
- Last Min Low: $0.262
- Last Min VWAP: $0.263
Company Profile
- Name: Intensity Therapeutics, Inc. Common stock
- Website: https://www.intensitytherapeutics.com
- Listed Date: 2023-06-30
- Location: SHELTON, CT
- Market Status: Active
- CIK Number: 0001567264
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $11.91M
- Round Lot: 100
- Outstanding Shares: 49.06M
- Asset Type: CS
RECENT FILINGS FOR INTS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-09-09 | DEFA14A | View |
| 2025-09-09 | DEF 14A | View |
| 2025-08-28 | PRE 14A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | 8-K | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-07-18 | 8-K | View |
| 2025-07-09 | SCHEDULE 13G/A | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-27 | S-8 | View |
| 2025-06-18 | 424B5 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-12 | 424B5 | View |
| 2025-06-11 | FWP | View |
| 2025-06-11 | 424B5 | View |
| 2025-06-11 | 424B5 | View |
Latest News on INTS